September 8-9, 2026: This 2-day workshop explored the factors involved in selecting endpoints and interpreting treatment effects in embedded pragmatic clinical trials (ePCTs) to best inform decision-making. A series of panels addressed considerations for selecting endpoints that reliably measure concepts of interest in ePCTs; influential factors in the analysis and interpretation of treatment effects; applications of multicomponent and hierarchical endpoints; and real-world examples of various endpoint strategies in ePCTs.
Agenda, Slides, and Recordings
Day 1: September 8
Welcome and Introduction
Wendy Weber, ND, PhD, MPH
David Shurtleff, PhD
Kevin Weinfurt, PhD
Opening Presentation: Defining the Endpoint: Where Evidence Begins
Kevin Weinfurt, PhD
Session 1: Aiming for Impact: What is the Right Concept to Target?
Moderator: Steven George, PT, PhD, FAPTA
Panel:
- Michael Ho, MD, PhD
- Frederick Masoudi, MD, MSPH, MACC, FAHA
- Miguel Vazquez, MD
- Tracy Wang, MD, MHS, MSc
- Wendy Weber, ND, PhD, MPH
Session 2: The Estimands Framework: Aligning Objectives, Endpoints, and Analyses
Moderator: Liz Turner, PhD
Panel:
- Elizabeth Colantuoni, PhD, ScM
- Fan Li, PhD
- Richard Skolasky, Jr, MA, ScD
- Hulin Wu, PhD
Session 3: Working With Multiple Outcomes: Multicomponent Endpoints and Beyond
Moderator: Emily O’Brien, PhD
Panel:
- Julie Fritz, PhD, PT
- Patrick Heagerty, PhD
- Eric Roseen, DC, PhD
- Pamela Shaw, PhD, MS
- Qilu Yu, PhD
Summary and Concluding Remarks
Steven George, PT, PhD, FAPTA
Emily O’Brien, PhD
Liz Turner, PhD
Kevin Weinfurt, PhD
Day 2: September 9
Welcome and Introduction
Wendy Weber, ND, PhD, MPH
David Shurtleff, PhD
Kevin Weinfurt, PhD
Opening Presentation: Moving From Measurement to Meaning
Kevin Weinfurt, PhD
Session 4: Unpacking Uncertainty, Meaningfulness, and Magnitude
Moderator: Greg Simon, MD, MPH
Panel:
- Devon Check, PhD
- Lynn DeBar, PhD, MPH
- Juan Marcos Gonzalez, PhD
- Laura Lee Johnson, PhD
- Natalia Morone, MD, MS
Session 5: Toward Best Practices for Interpretation of Endpoints
Moderators: Adrian Hernandez, MD, MHS; Kevin Weinfurt, PhD
Panel:
- Andrea Cook, PhD
- Corita Grudzen, MD, MSHS
- Liz Turner, PhD
- Kari Stephens, PhD
- Christy Zigler, PhD, MSEd
Summary and Concluding Remarks
Patrick Heagerty, PhD
Adrian Hernandez, MD, MHS
Greg Simon, MD, MPH
Kevin Weinfurt, PhD

The NIH Pragmatic Trials Collaboratory will offer a full-day workshop at the 18th Annual Conference on the Science of Dissemination and Implementation in Health in National Harbor, Maryland. The workshop,
December 8, 2024: The NIH Pragmatic Trials Collaboratory hosted a workshop at AcademyHealth's 17th Annual Conference on the Science of Dissemination and Implementation in Health. The workshop introduced concepts in the design, conduct, and implementation of pragmatic clinical trials embedded in healthcare systems, with a focus on methods relevant to health services researchers.
In a new report from the NIH Pragmatic Trials Collaboratory, a team of bioethicists explores the ethical obligation to share aggregate results from pragmatic clinical trials with research participants. They conclude with recommendations for how to meet this obligation.
In a JAMA Viewpoint published online this week, leaders from the NIH Pragmatic Trials Collaboratory discuss the discordance between the results of pragmatic clinical trials and the implementation of those results in healthcare settings, even in settings that championed the work.